Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Kirk Ellis Smith, DO
Family Practice · MIDDLETOWN, OH · NPI 1730199985
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 506 | 111 |
| Gabapentin | Gabapentin | 356 | 57 |
| Levothyroxine Sodium | Levothyroxine Sodium | 309 | 55 |
| Amlodipine Besylate | Amlodipine Besylate | 260 | 37 |
| Potassium Chloride | Potassium Chloride | 229 | 41 |
| Eliquis | Apixaban | 193 | 34 |
| Sertraline Hcl | Sertraline Hcl | 189 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 181 | 33 |
| Metformin Hcl | Metformin Hcl | 164 | 29 |
| Donepezil Hcl | Donepezil Hcl | 162 | 28 |
| Lisinopril | Lisinopril | 154 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 153 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 151 | 24 |
| Divalproex Sodium | Divalproex Sodium | 146 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 146 | 36 |
| Omeprazole | Omeprazole | 146 | 32 |
| Furosemide | Furosemide | 144 | 45 |
| Trazodone Hcl | Trazodone Hcl | 144 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 123 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 119 | 19 |
| Torsemide | Torsemide | 111 | 19 |
| Losartan Potassium | Losartan Potassium | 104 | 21 |
| Mirtazapine | Mirtazapine | 104 | 24 |
| Memantine Hcl | Memantine Hcl | 98 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 91 | 20 |
| Levetiracetam | Levetiracetam | 88 | 15 |
| Methocarbamol | Methocarbamol | 86 | 29 |
| Carvedilol | Carvedilol | 79 | 19 |
| Risperidone | Risperidone | 77 | 13 |
| Allopurinol | Allopurinol | 70 | 15 |
| Benztropine Mesylate | Benztropine Mesylate | 70 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 67 | 28 |
| Latanoprost | Latanoprost | 66 | 11 |
| Tramadol Hcl | Tramadol Hcl | 66 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 64 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 61 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 57 | 13 |
| Meloxicam | Meloxicam | 55 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | suppressed |
| Finasteride | Finasteride | 51 | suppressed |
| Famotidine | Famotidine | 48 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 48 | suppressed |
| Baclofen | Baclofen | 47 | suppressed |
| Nystatin | Nystatin | 44 | 18 |
| Topiramate | Topiramate | 44 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 42 | suppressed |
| Lorazepam | Lorazepam | 41 | 14 |
| Ingrezza | Valbenazine Tosylate | 40 | suppressed |
| Atenolol | Atenolol | 39 | suppressed |
| Prednisone | Prednisone | 39 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | 13 |
| Doxepin Hcl | Doxepin Hcl | 37 | suppressed |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 37 | suppressed |
| Cephalexin | Cephalexin | 35 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | suppressed |
| Belsomra | Suvorexant | 34 | suppressed |
| Jardiance | Empagliflozin | 34 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 33 | 20 |
| Alprazolam | Alprazolam | 32 | suppressed |
| Carbamazepine | Carbamazepine | 32 | suppressed |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 31 | suppressed |
| Timolol Maleate | Timolol Maleate | 31 | suppressed |
| Klor-Con 10 | Potassium Chloride | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 27 | 15 |
| Midodrine Hcl | Midodrine Hcl | 27 | 13 |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Carbamazepine Er | Carbamazepine | 26 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 26 | 14 |
| Klor-Con 8 | Potassium Chloride | 26 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Clonazepam | Clonazepam | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 22 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 21 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 19 | 11 |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 19 | 13 |
| Memantine Hcl Er | Memantine Hcl | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 13 |
| Olanzapine | Olanzapine | 18 | suppressed |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 11 |
| Ibuprofen | Ibuprofen | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 13 |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Metolazone | Metolazone | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | suppressed |
| Amantadine | Amantadine Hcl | 14 | suppressed |
| Clozapine | Clozapine | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 14 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Mesalamine | Mesalamine | 13 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 13 | suppressed |
| Acetic Acid | Acetic Acid | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Tetrabenazine | Tetrabenazine | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Xarelto | Rivaroxaban | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Rebif Rebidose | Interferon Beta-1a/Albumin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error